Increased risk of infection and mortality in women after cardiac surgery related to allogeneic blood transfusion

Journal of Women's Health

Volumn 16, Issue 10, 2007, Pages 1412-1420

  Rogers, Mary A M ^a,b   Blumberg, Neil ^c   Heal, Joanna M ^c   Hicks Jr , George L ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; CONFIDENCE INTERVAL; CORONARY ARTERY BYPASS SURGERY; ERYTHROCYTE TRANSFUSION; FEMALE; HEART VALVE REPLACEMENT; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; IMMUNOMODULATION; INFECTION RISK; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; THROMBOCYTE TRANSFUSION;

ADULT; AGED; BLOOD TRANSFUSION; CONFIDENCE INTERVALS; CORONARY ARTERY BYPASS; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SEX DISTRIBUTION; SURGICAL WOUND INFECTION; TRANSPLANTATION, HOMOLOGOUS; UNITED STATES; WOMEN'S HEALTH;

EID: 36849080347     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2007.0397     Document Type: Article

References (31)

1. Jacobs AK. Women, ischemic heart disease, revascularization, and the gender gap. J Am Coll Cardiol 2006;47:63S.
2. Merrill C, Elixhauser A. Procedures in U.S. hospitals, 2003. Rockville, MD: Agency for Healthcare Research and Quality. HCUP fact book No. 7. AHRQ publication No. 06-0039. ISBN 1-58763-185-7, 2005.
3. Stover EP, Siegel LC, Parks R, et al. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: A 24-institution study. Anesthesiology 1998;88:327.
4. Opelz G, Terasaki PI. Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med 1978;299:799.
5. Blumberg N, Heal JM. Transfusion and recipient immune function. Arch Pathol Lab Med 1989;113:246.
6. Blumberg N, Triulzi DJ, Heal JM. Transfusion-induced immunomodulation and its clinical consequences. Transfusion Med Rev 1990;4(Suppl 1):24.
7. Murphy PJ, Connery C, Hicks GL Jr, Blumberg N. Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft operations. J Thoracic Cardiovasc Surg 1992;104:1092.
8. Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: A meta-analysis. J Trauma 2003;54:908.
9. Triulzi DJ, Blumberg N, Heal JM. Association of transfusion with postoperative bacterial infection. Crit Rev Clin Lab Sci 1990;28:95.
10. Taylor RW, Manganaro L, O'Brien J, Trottier SJ, Parkar N, Veremakis C. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med 2002;30:2249.
11. Leal-Novel SR, Rincón-Ferrari MD, Garcia-Curiel A, et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 2001;119:1461.
12. Koch CG, Liang L, Duncan AI. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006;34:1608.
13. Dunne JR, Riddle MS, Danko J, Hayden R, Petersen K. Blood transfusion is associated with infection and increased resource utilization in combat casualties. Am Surgeon 2006;72:619.
14. Scott BH, Seifert FC, Glass PS, et al. Blood use in patients undergoing coronary artery bypass surgery: Impact of cardiopulmonary bypass pump, hematocrit, gender, age, and body weight. Anesth Analg 2003;97:958.
15. Rogers MAM, Blumberg N, Saint SK, Kim C, Nallamothu BK, Langa KM. Allogeneic blood transfusions explain increased mortality in women after coronary artery bypass graft surgery. Am Heart J 2006;152:1028.
16. Khanna MP, Hebert PC, Fergusson DA. Review of the clinical practice literature on patient characteristics associated with perioperative allogeneic red blood cell transfusion. Transfus Med Rev 2003;17:110.
17. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: Anemia and blood transfusion in the critically ill - Current clinical practice in the United States. Crit Care Med 2004;32:39.
18. Carson JL, Hill S, Carless P, Hébert P, Henry D. Transfusion triggers: A systematic review of the literature. Transfus Med Rev 2002;16:187.
19. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409.
20. Hébert PC, Yetisir E, Martin C, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001;29:227.
21. Guru V, Fremes SE, Tu JV. Time-related mortality for women after coronary artery bypass graft surgery: A population-based study. J Thorac Cardiovasc Surg 2004;127:1158.
22. Hay SN, Scanga L, Brecher ME. Life, death, and the risk of transfusion: a university hospital experience. Transfusion 2006;46:1491.
23. Swanson K, Dwyre DM, Krochmal J, Raife TJ. Transfusion-related acute lung injury (TRALI): Clinical and pathophysiologic considerations. Lung 2006;184:177.
24. Rana R, Fernandez-Perez ER, Khan SA, et al. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: A retrospective study. Transfusion 2006;46:1478.
25. Spiess BD. Transfusion of blood products affects outcome in cardiac surgery. Semin Cardiothorac Vasc Anesth 2004;8:267.
26. Khan SY, Kelher MR, Heal JM, et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006;108:2455.
27. Twomley KM, Rao SV, Becker RC. Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions. J Thromb Thrombolysis 2006;21:167.
28. Siemionow M, Agaoglu G. Role of blood transfusion in transplantation: A review. J Reconstructive Microsurg 2005;21:555.
29. Fergusson D, Khanna MP, Tinmouth A, Hébert PC. Transfusion of leukoreduced red blood cells may decrease postoperative infections: Two meta-analyses of randomized controlled trials. Can J Anesth 2004;51:417.
30. Bilgin YM, van de Watering LM, Eijsman L, et al. Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation 2004;109:2755.
31. Goodnough LT, Shander A, Spence R. Bloodless medicine: Clinical care without allogeneic blood transfusion. Transfusion 2003;43:668.